Premature-termination-codons readthrough compounds

US9255088B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9255088-B2
Application numberUS-201313764748-A
CountryUS
Kind codeB2
Filing dateFeb 11, 2013
Priority dateAug 11, 2010
Publication dateFeb 9, 2016
Grant dateFeb 9, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Premature termination codons readthrough compounds, composition thereof, and methods of making and using the same are provided.

First claim

Opening claim text (preview).

We claim: 1. A compound having the ability to increase read through of premature termination codons (PTCs) in RNA, a pharmaceutically acceptable salt thereof, having a structure of formula (VIII): wherein: X is O; R 3 is an ortho, meta, or para group and is a hydrogen, halo, or nitro; and R 4 is hydrogen, —C(O)H, halo, or a C1-C6 group. 2. A compound having the ability to read through premature termination codons (PTCs) in RNA, a pharmaceutically acceptable salt thereof, having a structure of formula (IX): 3. The compound of claim 1 where the compound is selected from: 4. The compound of claim 1 , having one of the following formulas: 5. A composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier. 6. A method of treating or ameliorating a medical condition associated with premature termination codons (PTCs) in RNA, comprising: administering to a subject a compound according to claim 1 , wherein the subject has an ATM gene that encodes one or more PTCs, or a DMD gene that encodes one or more PTCs.

Assignees

Inventors

Classifications

  • having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton · CPC title

  • linked by a carbon chain containing only aliphatic carbon atoms · CPC title

  • of the same non-condensed six-membered aromatic ring · CPC title

  • containing carbocyclic rings other than six-membered · CPC title

  • the carbon skeleton being further substituted by singly-bound oxygen atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9255088B2 cover?
Premature termination codons readthrough compounds, composition thereof, and methods of making and using the same are provided.
Who is the assignee on this patent?
Univ California
What technology area does this patent fall under?
Primary CPC classification C07D413/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).